Ball Bryan's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Sep 15, 2026
- Accession no.
- 0001766522-26-000015
- Filed
- Sep 15, 2026, 7:05 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 derivative transactions. It was filed on the trade date.
This filing was later replaced by the amendment 0001766522-26-000017 (Sep 18, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ball BryanCIK 0001766522 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | AGrant or awardAcquired | +91,633 | $0.00 | $0 | 91,633 | Direct | |
| Sep 15, 2026 | Common Stock | AGrant or awardAcquired | +91,633 | $0.00 | $0 | 91,633 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Chief Technical Operations Officer